Baxalta Incorporated;UNIVERSITY OF CONNECTICUT;Baxalta GmbH
发明人:
Michael Pikal,Serguei Tchessalov,Erik Bjornson,Feroz Jameel,Marc Besman
申请号：
US16547409
公开号：
US20200078447A1
申请日:
2019.08.21
申请国别(地区):
US
年份:
2020
代理人:
摘要：
A Factor VIII (FVIII) composition formulated such that NaCl is not present in the final formulation or is present in trace amounts, which allows for a concomitant reduction in the lyophilization cycle time and increased stability of the lyophilized FVIII.
